ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610457 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610457; 2) Community: the network communities that were significantly associated with the response to NSC 610457; 3) Molecule: the relationships between components within communities and NSC 610457; 4) MDR: the compounds that were significantly associated with the NSC 610457.

NSC Compound Enrichment Correlation
NSC 683556 Camptothecin Derivative 0.0352383000003058 0.88878327
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0352383000003058 0.14908708
NSC 697504 Null 0.0352383000003058 0.21662697
NSC 697730 Null 0.0352383000003058 0.30612693
NSC 701743 Null 0.0352383000003058 0.79723451
NSC 710002 Null 0.0352383000003058 0.15548189
NSC 713759 Null 0.0352383000003058 0.31550901
NSC 732737 Null 0.0352383000003058 0.15395301
NSC 733891 arypurine derivatives 0.0352383000003058 0.09631607
NSC 752270 2,7-Bis-[3-(2-chloro-benzylamino)-propyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate 0.0352383000003058 0.084968198
Total:58  Current:39    [First] [Prev] [Next] [Last]